During the past decade, Mercer Bucks Oncology-Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercer Bucks Oncology-Hematology" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mercer Bucks Oncology-Hematology" are "Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Neoplasms, Lung" (1 trials) and "Neoplasms, Pulmonary" (1 trials). Many other conditions were trialed in "Mercer Bucks Oncology-Hematology" in a lesser frequency.

Most popular intervention types in "Mercer Bucks Oncology-Hematology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (1 trials), "gemcitabine hydrochloride" (1 trials), "paclitaxel" (1 trials), "pemetrexed" (1 trials) and "talabostat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercer Bucks Oncology-Hematology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mercer Bucks Oncology-Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mercer Bucks Oncology-Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercer Bucks Oncology-Hematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".